Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory

Marina Yamada, Tomohiro Chiba, Jumpei Sasabe, Mikiro Nawa, Hirohisa Tajima, Takako Niikura, Kenzo Terashita, Sadakazu Aiso, Yoshiko Kita, Masaaki Matsuoka, Ikuo Nishimoto

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Amyloid β (Aβ) is closely related to the onset of Alzheimer's disease (AD). To construct AD animal models, a bolus administration of a large dose of toxic Aβ into the cerebral ventricles of rodents has been performed in earlier studies. In parallel, a continuous infusion system via an osmotic pump into the cerebral ventricle has been developed to make a rat AD model. In this study, we developed a mouse AD model by repetitive administration of Aβ25-35 via a cannula implanted into the cerebral ventricle. Using this administration system, we reproducibly constructed a mouse with impaired spatial working memory. In accordance with the occurrence of the abnormal mouse behavior, we found that the number of choline acetyltransferase (ChAT)-positive neurons was reduced in paraventricular regions of brains of Aβ25-35- administered mice in a dose-dependent manner. Considering that the repetitive administration of a small dose of toxic Aβ via an implanted cannula leads to a brain status more resembling that of the AD patients than a bolus injection of a large dose of Aβ, and therapeutic as well as toxic agents are able to be repeatedly and reliably administered via an implanted cannula, we concluded that the implanted cannula-bearing AD mouse model is useful for development of new AD therapy.

Original languageEnglish
Pages (from-to)139-146
Number of pages8
JournalBehavioural Brain Research
Volume164
Issue number2
DOIs
Publication statusPublished - 2005 Nov 7

Fingerprint

Cerebral Ventricles
Short-Term Memory
Alzheimer Disease
Poisons
Choline O-Acetyltransferase
Brain
Cannula
Spatial Memory
Amyloid
Rodentia
Animal Models
Neurons
Injections
Therapeutics

Keywords

  • Alzheimer's disease
  • Amyloid beta (Aβ)
  • Implanted cannula
  • Spontaneous alternation behavior
  • Y-maze test

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory. / Yamada, Marina; Chiba, Tomohiro; Sasabe, Jumpei; Nawa, Mikiro; Tajima, Hirohisa; Niikura, Takako; Terashita, Kenzo; Aiso, Sadakazu; Kita, Yoshiko; Matsuoka, Masaaki; Nishimoto, Ikuo.

In: Behavioural Brain Research, Vol. 164, No. 2, 07.11.2005, p. 139-146.

Research output: Contribution to journalArticle

Yamada, M, Chiba, T, Sasabe, J, Nawa, M, Tajima, H, Niikura, T, Terashita, K, Aiso, S, Kita, Y, Matsuoka, M & Nishimoto, I 2005, 'Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory', Behavioural Brain Research, vol. 164, no. 2, pp. 139-146. https://doi.org/10.1016/j.bbr.2005.03.026
Yamada, Marina ; Chiba, Tomohiro ; Sasabe, Jumpei ; Nawa, Mikiro ; Tajima, Hirohisa ; Niikura, Takako ; Terashita, Kenzo ; Aiso, Sadakazu ; Kita, Yoshiko ; Matsuoka, Masaaki ; Nishimoto, Ikuo. / Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory. In: Behavioural Brain Research. 2005 ; Vol. 164, No. 2. pp. 139-146.
@article{df88a0921143417c9dadc50e9a8ed0e6,
title = "Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory",
abstract = "Amyloid β (Aβ) is closely related to the onset of Alzheimer's disease (AD). To construct AD animal models, a bolus administration of a large dose of toxic Aβ into the cerebral ventricles of rodents has been performed in earlier studies. In parallel, a continuous infusion system via an osmotic pump into the cerebral ventricle has been developed to make a rat AD model. In this study, we developed a mouse AD model by repetitive administration of Aβ25-35 via a cannula implanted into the cerebral ventricle. Using this administration system, we reproducibly constructed a mouse with impaired spatial working memory. In accordance with the occurrence of the abnormal mouse behavior, we found that the number of choline acetyltransferase (ChAT)-positive neurons was reduced in paraventricular regions of brains of Aβ25-35- administered mice in a dose-dependent manner. Considering that the repetitive administration of a small dose of toxic Aβ via an implanted cannula leads to a brain status more resembling that of the AD patients than a bolus injection of a large dose of Aβ, and therapeutic as well as toxic agents are able to be repeatedly and reliably administered via an implanted cannula, we concluded that the implanted cannula-bearing AD mouse model is useful for development of new AD therapy.",
keywords = "Alzheimer's disease, Amyloid beta (Aβ), Implanted cannula, Spontaneous alternation behavior, Y-maze test",
author = "Marina Yamada and Tomohiro Chiba and Jumpei Sasabe and Mikiro Nawa and Hirohisa Tajima and Takako Niikura and Kenzo Terashita and Sadakazu Aiso and Yoshiko Kita and Masaaki Matsuoka and Ikuo Nishimoto",
year = "2005",
month = "11",
day = "7",
doi = "10.1016/j.bbr.2005.03.026",
language = "English",
volume = "164",
pages = "139--146",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Implanted cannula-mediated repetitive administration of Aβ25-35 into the mouse cerebral ventricle effectively impairs spatial working memory

AU - Yamada, Marina

AU - Chiba, Tomohiro

AU - Sasabe, Jumpei

AU - Nawa, Mikiro

AU - Tajima, Hirohisa

AU - Niikura, Takako

AU - Terashita, Kenzo

AU - Aiso, Sadakazu

AU - Kita, Yoshiko

AU - Matsuoka, Masaaki

AU - Nishimoto, Ikuo

PY - 2005/11/7

Y1 - 2005/11/7

N2 - Amyloid β (Aβ) is closely related to the onset of Alzheimer's disease (AD). To construct AD animal models, a bolus administration of a large dose of toxic Aβ into the cerebral ventricles of rodents has been performed in earlier studies. In parallel, a continuous infusion system via an osmotic pump into the cerebral ventricle has been developed to make a rat AD model. In this study, we developed a mouse AD model by repetitive administration of Aβ25-35 via a cannula implanted into the cerebral ventricle. Using this administration system, we reproducibly constructed a mouse with impaired spatial working memory. In accordance with the occurrence of the abnormal mouse behavior, we found that the number of choline acetyltransferase (ChAT)-positive neurons was reduced in paraventricular regions of brains of Aβ25-35- administered mice in a dose-dependent manner. Considering that the repetitive administration of a small dose of toxic Aβ via an implanted cannula leads to a brain status more resembling that of the AD patients than a bolus injection of a large dose of Aβ, and therapeutic as well as toxic agents are able to be repeatedly and reliably administered via an implanted cannula, we concluded that the implanted cannula-bearing AD mouse model is useful for development of new AD therapy.

AB - Amyloid β (Aβ) is closely related to the onset of Alzheimer's disease (AD). To construct AD animal models, a bolus administration of a large dose of toxic Aβ into the cerebral ventricles of rodents has been performed in earlier studies. In parallel, a continuous infusion system via an osmotic pump into the cerebral ventricle has been developed to make a rat AD model. In this study, we developed a mouse AD model by repetitive administration of Aβ25-35 via a cannula implanted into the cerebral ventricle. Using this administration system, we reproducibly constructed a mouse with impaired spatial working memory. In accordance with the occurrence of the abnormal mouse behavior, we found that the number of choline acetyltransferase (ChAT)-positive neurons was reduced in paraventricular regions of brains of Aβ25-35- administered mice in a dose-dependent manner. Considering that the repetitive administration of a small dose of toxic Aβ via an implanted cannula leads to a brain status more resembling that of the AD patients than a bolus injection of a large dose of Aβ, and therapeutic as well as toxic agents are able to be repeatedly and reliably administered via an implanted cannula, we concluded that the implanted cannula-bearing AD mouse model is useful for development of new AD therapy.

KW - Alzheimer's disease

KW - Amyloid beta (Aβ)

KW - Implanted cannula

KW - Spontaneous alternation behavior

KW - Y-maze test

UR - http://www.scopus.com/inward/record.url?scp=25144516321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144516321&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2005.03.026

DO - 10.1016/j.bbr.2005.03.026

M3 - Article

VL - 164

SP - 139

EP - 146

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 2

ER -